GLP-1 receptor agonists are revolutionizing weight loss, but they can come with side effects
The American Journal of Psychiatry, 152 (5), 792794
GLP1 therapies can deliver impressive weight loss (15%), but most people regain weight after stopping treatment (Panel A)
Without deliberate attention to dietary composition, muscle loss accelerates alongside fat loss, and his long-term metabolic health doesnt improve as much as the scale suggests
Many patients notice reduced appetite, better portion control, and greater stability in blood sugar levels
When used thoughtfully, weight loss injections can support healthier outcomes while minimizing risks